Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system

Abstract Objective: Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI. Design: Retrospective cohort study. Setting: Veterans Health Administrat...

Full description

Bibliographic Details
Main Authors: Leila S. Hojat, Brigid M. Wilson, Federico Perez, Maria F. Mojica, Mendel E. Singer, Robert A. Bonomo, Lauren H. Epstein
Format: Article
Language:English
Published: Cambridge University Press 2023-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article
_version_ 1827583925996748800
author Leila S. Hojat
Brigid M. Wilson
Federico Perez
Maria F. Mojica
Mendel E. Singer
Robert A. Bonomo
Lauren H. Epstein
author_facet Leila S. Hojat
Brigid M. Wilson
Federico Perez
Maria F. Mojica
Mendel E. Singer
Robert A. Bonomo
Lauren H. Epstein
author_sort Leila S. Hojat
collection DOAJ
description Abstract Objective: Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI. Design: Retrospective cohort study. Setting: Veterans Health Administration. Patients: Hospitalized patients with PA-BSI in pre-COVID-19 (January 2009 to December 2019) and COVID-19 (January 2020 to June 2022) periods. Patients in the COVID-19 period were further stratified by the presence or absence of concomitant COVID-19 infection. Methods: We characterized trends in resistance, treatment, and mortality over the study period. Multivariable logistic regression and modified Poisson analyses were used to determine the association between COVID-19 and mortality among patients with PA-BSI. Additional predictors included demographics, comorbidities, disease severity, antimicrobial susceptibility, and treatment. Results: A total of 6,714 patients with PA-BSI were identified. Throughout the study period, PA resistance rates decreased. Mortality decreased during the pre-COVID-19 period and increased during the COVID-19 period. Mortality was not significantly different between pre-COVID-19 (24.5%, 95% confidence interval [CI] 23.3–28.6) and COVID-19 period/COVID-negative (26.0%, 95% CI 23.5–28.6) patients, but it was significantly higher in COVID-19 period/COVID-positive patients (47.2%, 35.3–59.3). In the modified Poisson analysis, COVID-19 coinfection was associated with higher mortality (relative risk 1.44, 95% CI 1.01–2.06). Higher Charlson Comorbidity Index, higher modified Acute Physiology and Chronic Health Evaluation score, and no targeted PA-BSI treatment within 48 h were also predictors of higher mortality. Conclusions: Higher mortality was observed in patients with COVID-19 coinfection among patients with PA-BSI. Future studies should explore this relationship in other settings and investigate potential SARS-CoV-2 and PA synergy.
first_indexed 2024-03-08T23:21:10Z
format Article
id doaj.art-bc4c806df9f649f290672a169257ee5d
institution Directory Open Access Journal
issn 2732-494X
language English
last_indexed 2024-03-08T23:21:10Z
publishDate 2023-01-01
publisher Cambridge University Press
record_format Article
series Antimicrobial Stewardship & Healthcare Epidemiology
spelling doaj.art-bc4c806df9f649f290672a169257ee5d2023-12-15T06:28:34ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2023-01-01310.1017/ash.2023.455Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration systemLeila S. Hojat0https://orcid.org/0000-0003-4364-8141Brigid M. Wilson1https://orcid.org/0000-0003-2966-2940Federico Perez2Maria F. Mojica3https://orcid.org/0000-0002-1380-9824Mendel E. Singer4https://orcid.org/0000-0002-3331-3340Robert A. Bonomo5Lauren H. Epstein6Department of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USA Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USACase Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA Research Service, VA Northeast Ohio Healthcare System, Cleveland, OH, USA Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, Colombia Departments of Pathology, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USADepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USA Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA Research Service, VA Northeast Ohio Healthcare System, Cleveland, OH, USA Departments of Pathology, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USAInfectious Diseases, US Department of Veterans Affairs Medical Center, Decatur, GA, USA Abstract Objective: Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI. Design: Retrospective cohort study. Setting: Veterans Health Administration. Patients: Hospitalized patients with PA-BSI in pre-COVID-19 (January 2009 to December 2019) and COVID-19 (January 2020 to June 2022) periods. Patients in the COVID-19 period were further stratified by the presence or absence of concomitant COVID-19 infection. Methods: We characterized trends in resistance, treatment, and mortality over the study period. Multivariable logistic regression and modified Poisson analyses were used to determine the association between COVID-19 and mortality among patients with PA-BSI. Additional predictors included demographics, comorbidities, disease severity, antimicrobial susceptibility, and treatment. Results: A total of 6,714 patients with PA-BSI were identified. Throughout the study period, PA resistance rates decreased. Mortality decreased during the pre-COVID-19 period and increased during the COVID-19 period. Mortality was not significantly different between pre-COVID-19 (24.5%, 95% confidence interval [CI] 23.3–28.6) and COVID-19 period/COVID-negative (26.0%, 95% CI 23.5–28.6) patients, but it was significantly higher in COVID-19 period/COVID-positive patients (47.2%, 35.3–59.3). In the modified Poisson analysis, COVID-19 coinfection was associated with higher mortality (relative risk 1.44, 95% CI 1.01–2.06). Higher Charlson Comorbidity Index, higher modified Acute Physiology and Chronic Health Evaluation score, and no targeted PA-BSI treatment within 48 h were also predictors of higher mortality. Conclusions: Higher mortality was observed in patients with COVID-19 coinfection among patients with PA-BSI. Future studies should explore this relationship in other settings and investigate potential SARS-CoV-2 and PA synergy. https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article
spellingShingle Leila S. Hojat
Brigid M. Wilson
Federico Perez
Maria F. Mojica
Mendel E. Singer
Robert A. Bonomo
Lauren H. Epstein
Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
Antimicrobial Stewardship & Healthcare Epidemiology
title Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
title_full Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
title_fullStr Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
title_full_unstemmed Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
title_short Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
title_sort association of covid 19 coinfection with increased mortality among patients with pseudomonas aeruginosa bloodstream infection in the veterans health administration system
url https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article
work_keys_str_mv AT leilashojat associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT brigidmwilson associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT federicoperez associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT mariafmojica associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT mendelesinger associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT robertabonomo associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem
AT laurenhepstein associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem